Selected research
Industry Growth & Trends
Global Large-Scale Oligonucleotide Synthesis Services Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Large-Scale Oligonucleotide Synthesis Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Large-Scale Oligonucleotide Synthesis Services is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Large-Scale Oligonucleotide Synthesis Services is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Large-Scale Oligonucleotide Synthesis Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Large-Scale Oligonucleotide Synthesis Services market include Thermo Fisher Scientific, Merck, Genscript, Guangzhou RiboBio, Tsingke, Abace Biotechnology, TriLink BioTechnologies, Synbio Technologies and Macrogen, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Large-Scale Oligonucleotide Synthesis Services market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Large-Scale Oligonucleotide Synthesis Services market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Large-Scale Oligonucleotide Synthesis Services market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Large-Scale Oligonucleotide Synthesis Services.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Large-Scale Oligonucleotide Synthesis Services market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Large-Scale Oligonucleotide Synthesis Services Market by Company
Thermo Fisher Scientific
Merck
Genscript
Guangzhou RiboBio
Tsingke
Abace Biotechnology
TriLink BioTechnologies
Synbio Technologies
Macrogen
Integrated DNA Technologies (IDT)
Eurogentec
Cusabio
BBI Life Sciences
Azenta Life Sciences
Aurigene Pharmaceutical Services
Large-Scale Oligonucleotide Synthesis Services Segment by Type
Common Primer Synthesis
Modified Primer Synthesis
Large-Scale Oligonucleotide Synthesis Services Segment by Application
Biotech Company
Academic Scientific Research Institution
Large-Scale Oligonucleotide Synthesis Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Large-Scale Oligonucleotide Synthesis Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Large-Scale Oligonucleotide Synthesis Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Large-Scale Oligonucleotide Synthesis Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Large-Scale Oligonucleotide Synthesis Services companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Common Primer Synthesis
- Modified Primer Synthesis
Applications
- Biotech Company
- Academic Scientific Research Institution
Companies covered
- Thermo Fisher Scientific
- Merck
- Genscript
- Guangzhou RiboBio
- Tsingke
- Abace Biotechnology
- TriLink BioTechnologies
- Synbio Technologies
- Macrogen
- Integrated DNA Technologies (IDT)
- Eurogentec
- Cusabio
- BBI Life Sciences
- Azenta Life Sciences
- Aurigene Pharmaceutical Services
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Large-Scale Oligonucleotide Synthesis Services Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Large-Scale Oligonucleotide Synthesis Services Market Size by Region (2021-2032)
- 1.4.1 Global Large-Scale Oligonucleotide Synthesis Services Market Size by Region (2021-2026)
- 1.4.2 Global Large-Scale Oligonucleotide Synthesis Services Market Size by Region (2027-2032)
- 1.5 Key Regions Large-Scale Oligonucleotide Synthesis Services Market Size (2021-2032)
- 1.5.1 North America Large-Scale Oligonucleotide Synthesis Services Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Large-Scale Oligonucleotide Synthesis Services Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Large-Scale Oligonucleotide Synthesis Services Market Size Growth Rate (2021-2032)
- 1.5.4 South America Large-Scale Oligonucleotide Synthesis Services Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Large-Scale Oligonucleotide Synthesis Services Market Size Growth Rate (2021-2032)
2 Large-Scale Oligonucleotide Synthesis Services Market by Type
- 2.1 Type Introduction
- 2.1.1 Common Primer Synthesis
- 2.1.2 Modified Primer Synthesis
- 2.2 Global Large-Scale Oligonucleotide Synthesis Services Market Size by Type
- 2.2.1 Global Large-Scale Oligonucleotide Synthesis Services Market Size Overview by Type (2021-2032)
- 2.2.2 Global Large-Scale Oligonucleotide Synthesis Services Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Large-Scale Oligonucleotide Synthesis Services Market Size Forecasted by Type (2027-2032)
- 2.3 Global Large-Scale Oligonucleotide Synthesis Services Market Size by Regions
- 2.3.1 North America Large-Scale Oligonucleotide Synthesis Services Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Large-Scale Oligonucleotide Synthesis Services Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Large-Scale Oligonucleotide Synthesis Services Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Large-Scale Oligonucleotide Synthesis Services Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Large-Scale Oligonucleotide Synthesis Services Market Size Breakdown by Type (2021-2026)
3 Large-Scale Oligonucleotide Synthesis Services Market by Application
- 3.1 Type Introduction
- 3.1.1 Biotech Company
- 3.1.2 Academic Scientific Research Institution
- 3.2 Global Large-Scale Oligonucleotide Synthesis Services Market Size by Application
- 3.2.1 Global Large-Scale Oligonucleotide Synthesis Services Market Size Overview by Application (2021-2032)
- 3.2.2 Global Large-Scale Oligonucleotide Synthesis Services Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Large-Scale Oligonucleotide Synthesis Services Market Size Forecasted by Application (2027-2032)
- 3.3 Global Large-Scale Oligonucleotide Synthesis Services Market Size by Regions
- 3.3.1 North America Large-Scale Oligonucleotide Synthesis Services Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Large-Scale Oligonucleotide Synthesis Services Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Large-Scale Oligonucleotide Synthesis Services Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Large-Scale Oligonucleotide Synthesis Services Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Large-Scale Oligonucleotide Synthesis Services Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Large-Scale Oligonucleotide Synthesis Services Industry Trends
- 4.2 Large-Scale Oligonucleotide Synthesis Services Industry Drivers
- 4.3 Large-Scale Oligonucleotide Synthesis Services Industry Opportunities and Challenges
- 4.4 Large-Scale Oligonucleotide Synthesis Services Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Large-Scale Oligonucleotide Synthesis Services Revenue (2021-2026)
- 5.2 Global Large-Scale Oligonucleotide Synthesis Services Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Large-Scale Oligonucleotide Synthesis Services Key Company Headquarters & Area Served
- 5.4 Global Large-Scale Oligonucleotide Synthesis Services Company, Product Type & Application
- 5.5 Global Large-Scale Oligonucleotide Synthesis Services Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Large-Scale Oligonucleotide Synthesis Services Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Large-Scale Oligonucleotide Synthesis Services Players Market Share by Revenue in 2025
- 5.6.3 2025 Large-Scale Oligonucleotide Synthesis Services Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Thermo Fisher Scientific
- 6.1.1 Thermo Fisher Scientific Company Information
- 6.1.2 Thermo Fisher Scientific Business Overview
- 6.1.3 Thermo Fisher Scientific Large-Scale Oligonucleotide Synthesis Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Thermo Fisher Scientific Large-Scale Oligonucleotide Synthesis Services Product Portfolio
- 6.1.5 Thermo Fisher Scientific Recent Developments
- 6.2 Merck
- 6.2.1 Merck Company Information
- 6.2.2 Merck Business Overview
- 6.2.3 Merck Large-Scale Oligonucleotide Synthesis Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Merck Large-Scale Oligonucleotide Synthesis Services Product Portfolio
- 6.2.5 Merck Recent Developments
- 6.3 Genscript
- 6.3.1 Genscript Company Information
- 6.3.2 Genscript Business Overview
- 6.3.3 Genscript Large-Scale Oligonucleotide Synthesis Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Genscript Large-Scale Oligonucleotide Synthesis Services Product Portfolio
- 6.3.5 Genscript Recent Developments
- 6.4 Guangzhou RiboBio
- 6.4.1 Guangzhou RiboBio Company Information
- 6.4.2 Guangzhou RiboBio Business Overview
- 6.4.3 Guangzhou RiboBio Large-Scale Oligonucleotide Synthesis Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Guangzhou RiboBio Large-Scale Oligonucleotide Synthesis Services Product Portfolio
- 6.4.5 Guangzhou RiboBio Recent Developments
- 6.5 Tsingke
- 6.5.1 Tsingke Company Information
- 6.5.2 Tsingke Business Overview
- 6.5.3 Tsingke Large-Scale Oligonucleotide Synthesis Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Tsingke Large-Scale Oligonucleotide Synthesis Services Product Portfolio
- 6.5.5 Tsingke Recent Developments
- 6.6 Abace Biotechnology
- 6.6.1 Abace Biotechnology Company Information
- 6.6.2 Abace Biotechnology Business Overview
- 6.6.3 Abace Biotechnology Large-Scale Oligonucleotide Synthesis Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Abace Biotechnology Large-Scale Oligonucleotide Synthesis Services Product Portfolio
- 6.6.5 Abace Biotechnology Recent Developments
- 6.7 TriLink BioTechnologies
- 6.7.1 TriLink BioTechnologies Company Information
- 6.7.2 TriLink BioTechnologies Business Overview
- 6.7.3 TriLink BioTechnologies Large-Scale Oligonucleotide Synthesis Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 TriLink BioTechnologies Large-Scale Oligonucleotide Synthesis Services Product Portfolio
- 6.7.5 TriLink BioTechnologies Recent Developments
- 6.8 Synbio Technologies
- 6.8.1 Synbio Technologies Company Information
- 6.8.2 Synbio Technologies Business Overview
- 6.8.3 Synbio Technologies Large-Scale Oligonucleotide Synthesis Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Synbio Technologies Large-Scale Oligonucleotide Synthesis Services Product Portfolio
- 6.8.5 Synbio Technologies Recent Developments
- 6.9 Macrogen
- 6.9.1 Macrogen Company Information
- 6.9.2 Macrogen Business Overview
- 6.9.3 Macrogen Large-Scale Oligonucleotide Synthesis Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Macrogen Large-Scale Oligonucleotide Synthesis Services Product Portfolio
- 6.9.5 Macrogen Recent Developments
- 6.10 Integrated DNA Technologies (IDT)
- 6.10.1 Integrated DNA Technologies (IDT) Company Information
- 6.10.2 Integrated DNA Technologies (IDT) Business Overview
- 6.10.3 Integrated DNA Technologies (IDT) Large-Scale Oligonucleotide Synthesis Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Integrated DNA Technologies (IDT) Large-Scale Oligonucleotide Synthesis Services Product Portfolio
- 6.10.5 Integrated DNA Technologies (IDT) Recent Developments
- 6.11 Eurogentec
- 6.11.1 Eurogentec Company Information
- 6.11.2 Eurogentec Business Overview
- 6.11.3 Eurogentec Large-Scale Oligonucleotide Synthesis Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Eurogentec Large-Scale Oligonucleotide Synthesis Services Product Portfolio
- 6.11.5 Eurogentec Recent Developments
- 6.12 Cusabio
- 6.12.1 Cusabio Company Information
- 6.12.2 Cusabio Business Overview
- 6.12.3 Cusabio Large-Scale Oligonucleotide Synthesis Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Cusabio Large-Scale Oligonucleotide Synthesis Services Product Portfolio
- 6.12.5 Cusabio Recent Developments
- 6.13 BBI Life Sciences
- 6.13.1 BBI Life Sciences Company Information
- 6.13.2 BBI Life Sciences Business Overview
- 6.13.3 BBI Life Sciences Large-Scale Oligonucleotide Synthesis Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 BBI Life Sciences Large-Scale Oligonucleotide Synthesis Services Product Portfolio
- 6.13.5 BBI Life Sciences Recent Developments
- 6.14 Azenta Life Sciences
- 6.14.1 Azenta Life Sciences Company Information
- 6.14.2 Azenta Life Sciences Business Overview
- 6.14.3 Azenta Life Sciences Large-Scale Oligonucleotide Synthesis Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Azenta Life Sciences Large-Scale Oligonucleotide Synthesis Services Product Portfolio
- 6.14.5 Azenta Life Sciences Recent Developments
- 6.15 Aurigene Pharmaceutical Services
- 6.15.1 Aurigene Pharmaceutical Services Company Information
- 6.15.2 Aurigene Pharmaceutical Services Business Overview
- 6.15.3 Aurigene Pharmaceutical Services Large-Scale Oligonucleotide Synthesis Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Aurigene Pharmaceutical Services Large-Scale Oligonucleotide Synthesis Services Product Portfolio
- 6.15.5 Aurigene Pharmaceutical Services Recent Developments
7 North America
- 7.1 North America Large-Scale Oligonucleotide Synthesis Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Large-Scale Oligonucleotide Synthesis Services Market Size by Country (2021-2026)
- 7.3 North America Large-Scale Oligonucleotide Synthesis Services Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Large-Scale Oligonucleotide Synthesis Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Large-Scale Oligonucleotide Synthesis Services Market Size by Country (2021-2026)
- 8.3 Europe Large-Scale Oligonucleotide Synthesis Services Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Large-Scale Oligonucleotide Synthesis Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Large-Scale Oligonucleotide Synthesis Services Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Large-Scale Oligonucleotide Synthesis Services Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Large-Scale Oligonucleotide Synthesis Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Large-Scale Oligonucleotide Synthesis Services Market Size by Country (2021-2026)
- 10.3 South America Large-Scale Oligonucleotide Synthesis Services Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Large-Scale Oligonucleotide Synthesis Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Large-Scale Oligonucleotide Synthesis Services Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Large-Scale Oligonucleotide Synthesis Services Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst